gip and glp-1 pathways The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology This review summarizes how GLP-1

l-carnitinemetabolic functions and meaning in humans life

Semaglutide (Wegovy) for chronic weight management requires age 18 and older

SGLT2 inhibitors are now authorised for the treatment of chronic kidney disease and heart failure in individuals with or without T2DM [1, 2]

Feb 1 2021;229:113252

it also helps reduce muscle soreness post-exercise, potentially enhancing recovery

Diabetes (2011) 60(7):191725.10.2337/db10-1707 5 SellHBluherMKlotingNSchlichRWillemsMRuppeFet alAdipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro